Pulmonary hypertension associated with sarcoidosis

Arthritis Research and Therapy

Volumn 9, Issue SUPPL. 2, 2007, Pages

  Baughman, Robert P ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANTIINFLAMMATORY AGENT; AZATHIOPRINE; BOSENTAN; CYCLOSPORIN; ENDOTHELIN 1; INFLIXIMAB; INTERLEUKIN 8; METHOTREXATE; NIFEDIPINE; OXYGEN; PLACEBO; PREDNISONE; PROSTACYCLIN; STEROID; TUMOR NECROSIS FACTOR ALPHA; ENDOTHELIN RECEPTOR;

CELL PROLIFERATION; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG WITHDRAWAL; DYSPNEA; FIBROBLAST; HUMAN; HYPOXIA; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROSIS; LUNG LAVAGE; LUNG SARCOIDOSIS; PATHOGENESIS; PHENOTYPE; PROGNOSIS; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION; REVIEW; AGED; ANIMAL; CASE REPORT; DRUG ANTAGONISM; FEMALE; IMMUNOLOGY; MALE; MIDDLE AGED; SARCOIDOSIS;

AGED; ANIMALS; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; RECEPTORS, ENDOTHELIN; SARCOIDOSIS; SARCOIDOSIS, PULMONARY;

EID: 35348937772     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2192     Document Type: Review

References (40)

1. Baughman RP Judson MA Teirstein A Yeager H Rossman M Knatterud GL Thompson B Presenting characteristics as predictors of duration of treatment in sarcoidosis QJM 2006 99 307-315 10.1093/qjmed/hcl038 16595563
2. Bihl MP Laule-Kilian K Bubendorf L Rutherford RM Baty F Kehren J Eryuksel E Staedtler F Yang JQ Goulet S Progressive pulmonary sarcoidosis: A fibroproliferative process potentially triggered by EGR-1 and IL-6 Sarcoidosis Vasc Diffuse Lung Dis 2006 23 38-50 16933469
3. Eishi Y Suga M Ishige I Kobayashi D Yamada T Takemura T Takizawa T Koike M Kudoh S Costabel U et al. Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis J Clin Microbiol 2002 40 198-204 120089 11773116 10.1128/JCM.40.1.198-204.2002
4. Baughman RP Lower EE du Bois RM Sarcoidosis Lancet 2003 361 1111-1118 10.1016/S0140-6736(03)12888-7 12672326
5. Baughman RP Iannuzzi M Tumour necrosis factor in sarcoidosis and its potential for targeted therapy BioDrugs 2003 17 425-431 10.2165/ 00063030-200317060-00005 14614765
6. Hunninghake GW Fulmer JD Young RC Jr Gadek JE Crystal RG Localization of the immune response in sarcoidosis Am Rev Respir Dis 1979 120 49-57 313729
7. Lower EE Baughman RP Prolonged use of MTX for sarcoidosis Arch Intern Med 1995 155 846-851 10.1001/archinte.155.8.846 7717793
8. Baughman RP Winget DB Lower EE Methotrexate is steroid sparing in acute sarcoidosis: Results of a double blind, randomized trial Sarcoidosis Vasc Diffuse Lung Dis 2000 17 60-66 10746262
9. Vancheeswaran R Magoulas T Efrat G Wheeler-Jones C Olsen I Penny R Black CM Circulating endothelin-1 levels in systemic sclerosis subsets: A marker of fibrosis or vascular dysfunction? J Rheumatol 1994 21 1838-1844 7837147
10. Kanno K Hirata Y Emori T Ohta K Shichiri M Shinohara S Chida Y Tomura S Marumo F Endothelin and Raynaud's phenomenon Am J Med 1991 90 130-132 10.1016/0002-9343(91)90519-4 1986582
11. Biondi ML Marasini B Bassani C Agastoni A Increased plasma endothelin levels in patients with Raynaud's phenomenon N Engl J Med 1991 324 1139-1140 2008192
12. Sofia M Mormile M Faraone S Alifano M Carratu P Carratu L Endothelin-1 excretion in urine in active pulmonary sarcoidosis and in other interstitial lung diseases Sarcoidosis 1995 12 118-123 8532958
13. Uguccioni M Pulsatelli L Grigolo B Facchini A Fasano L Cinti C Fabbri M Gasbarrini G Meliconi R Endothelin-1 in idiopathic pulmonary fibrosis J Clin Pathol 1995 48 330-334 502551 7615852 10.1136/jcp.48.4.330
14. Giaid A Michel RP Stewart DJ Sheppard M Corrin B Hamid Q Expression of endothelin-1 in lungs of patients with cryptogenic fibrosing alveolitis Lancet 1993 341 1550-1554 10.1016/0140-6736(93)90694-C 8099638
15. Letizia C Danese A Reale MG Caliumi C Delfini E Subioli S Cerci S D'Erasmo E Plasma levels of endothelin-1 increase in patients with sarcoidosis and fall after disease remission Panminerva Med 2001 43 257-261 11677420
16. DeRemee RA Sarcoidosis Mayo Clin Proc 1995 70 177-181 7845043
17. Pietinalho A Ohmichi M Lofroos AB Hiraga Y Selroos O The prognosis of pulmonary sarcoidosis in Finland and Hokkaido, Japan. A comparative five-year study of biopsy-proven cases Sarcoidosis Vasc Diffuse Lung Dis 2000 17 158-166 10957764
18. Reichenberger F Schauer J Kellner K Sack U Stiehl P Winkler J Different expression of endothelin in the bronchoalveolar lavage in patients with pulmonary diseases Lung 2001 179 163-174 10.1007/s004080000058 11891606
19. Terashita K Kato S Sata M Inoue S Nakamura H Tomoike H Increased endothelin-1 levels of BAL fluid in patients with pulmonary sarcoidosis Respirology 2006 11 145-151 10.1111/j.1440-1843.2006.00826.x 16548898
20. Shahar I Fireman E Topilsky M Grief J Schwarz Y Kivity S Ben-Efraim S Spirer Z Effect of endothelin-1 on alpha-smooth muscle actin expression and on alveolar fibroblasts proliferation in interstitial lung diseases Int J Immunopharmacol 1999 21 759-775 10.1016/S0192-0561(99)00056-9 10576621
21. Arcasoy SM Christie JD Pochettino A Rosengard BR Blumenthal NP Bavaria JE Kotloff RM Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation Chest 2001 120 873-880 10.1378/ chest.120.3.873 11555523
22. Shorr AF Davies DB Nathan SD Predicting mortality in patients with sarcoidosis awaiting lung transplantation Chest 2003 124 922-928 10.1378/ chest.124.3.922 12970018
23. Sulica R Teirstein AS Kakarla S Nemani N Behnegar A Padilla ML Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hypertension Chest 2005 128 1483-1489 10.1378/chest.128.3.1483 16162747
24. Rizzato G Pezzano A Sala G Merlini R Ladelli L Tansini G Montanari G Bertoli L Right heart impairment in sarcoidosis: Haemodynamic and echocardiographic study Eur J Respir Dis 1983 64 121-128 6219888
25. Barst RJ Ratner SJ Sarcoidosis and reactive pulmonary hypertension Arch Intern Med 1985 145 2112-2114 10.1001/archinte.145.11.2112 4062465
26. Nunes H Humbert M Capron F Brauner M Sitbon O Battesti JP Simonneau G Valeyre D Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis Thorax 2006 61 68-74 10.1136/ thx.2005.042838 16227329
27. Preston IR Klinger JR Landzberg MJ Houtchens J Nelson D Hill NS Vasoresponsiveness of sarcoidosis-associated pulmonary hypertension Chest 2001 120 866-872 10.1378/chest.120.3.866 11555522
28. Rolfes DB Weiss MA Sanders MA Necrotizing sarcoid granulomatosis with suppurative features Am J Clin Pathol 1984 82 602- 607 6093497
29. Popper HH Klemen H Colby TV Churg A Necrotizing sarcoid granulomatosis - is it different from nodular sarcoidosis? Pneumologie 2003 57 268-271 10.1055/s-2003-39365 12784179
30. Baughman RP Drent M Kavuru M Judson MA Costabel U du Bois R Albera C Brutsche M Davis G Donohue JF et al. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement Am J Respir Crit Care Med 2006 174 795-802 10.1164/rccm.200603-402OC 16840744
31. Baughman RP Engel PJ Meyer CA Barrett AB Lower EE Pulmonary hypertension in sarcoidosis Sarcoidosis Vasc Diffuse Lung Dis 2006 16933471
32. Foley RJ Metersky ML Successful treatment of sarcoidosis-associated pulmonary hypertension with bosentan Respiration 2005 16293957
33. Sharma S Kashour T Philipp R Secondary pulmonary arterial hypertension: treated with endothelin receptor blockade Tex Heart Inst J 2005 32 405-410 1336721 16392231
34. Doughan AR Williams BR Cardiac sarcoidosis Heart 2006 92 282-288 10.1136/ hrt.2005.080481 16415205
35. Salazar A Mana J Sala J Landoni BR Manresa F Combined portal and pulmonary hypertension in sarcoidosis Respiration 1994 61 117-119 8008988
36. Portier F Lerebours-Pigeonniere G Thiberville L Dominique S Tayot J Muir JF Nouvet G Sarcoidosis simulating a pulmonary veno-occlusive disease Rev Mal Respir 1991 8 101-102 2034841
37. Hoffstein V Ranganathan N Mullen JB Sarcoidosis simulating pulmonary veno-occlusive disease Am Rev Respir Dis 1986 134 809-811 3767134
38. Resten A Maitre S Capron F Simonneau G Musset D Pulmonary hypertension: CT findings in pulmonary veno-occlusive disease J Radiol 2003 84 1739-1745 15022986
39. Palmer SM Robinson LJ Wang A Gossage JR Bashore T Tapson VF Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease Chest 1998 113 237-240 9440597
40. Simonneau G Galie N Rubin LJ Langleben D Seeger W Domenighetti G Gibbs S Lebrec D Speich R Beghetti M et al. Clinical classification of pulmonary hypertension J Am Coll Cardiol 2004 Suppl S 5S-12S 10.1016/ j.jacc.2004.02.037